BARER SOL J bought TEVA

June 5, 2026 · Form 4 insider transaction

BARER SOL J bought 21,739 shares of Teva Pharmaceutical Industries Limited, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
21,739
Price
N/A
Total value
N/A
RoleDirector
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateJune 5, 2026
Filing dateJune 8, 2026
Shares owned after448,011
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

View the original Form 4 on SEC EDGAR